MODERN IDEAS ABOUT THE MECHANISM OF ANTINEOPLASTIC ACTION OF METHOTREXATE AND RESISTANCE TO IT
Abstract
The review of the literature devoted to mechanisms of action of methotrexate and prospects of chemotherapy of tumors. Prospects of development of chemotherapy and biotherapy seem to be optimistic in the situations when the potential of the surgical method of treatment of tumors seems practically exhausted. Constant intensive research in clinical and experimental oncology raises hopes for the further progress in this area and increase in an arsenal of struggle with malignant tumors.
About the Authors
D. V. NevozhajPoland
Wrozlaw
R. Budzynskaya
Poland
Wrozlaw
U. Kan’skaya
Poland
Wrozlaw
M. Yagello
Poland
Wrozlaw
Yu. Boratyn’sky
Poland
Wrozlaw
References
1. Владимирская Е.Б. Биологические основы противоопухолевой терапии. – М. : Агат-Мед, 2001.
2. Переводчикова Н.И. Руководство по химиотерапии опухолевых заболеваний. – М. : Практическая медицина, 2005.
3. Bertino J.R., Goker E., Gorlick R. et al. // Stem. Cells. – 1996. – Vol. 14. – P. 5–9.
4. Busch H. Methods in Cancer Research, vol. IV. – New York : Academic Press, 1968.
5. Chabner B.A., Longo D.L. Cancer chemotherapy and biotherapy: principles and practice. – Philadelphia : Lippincott Williams & Wilkins, 1996.
6. Dedhar S., Hartley D., Fitz-Gibbons D. et al. // J. Clin. Oncol. – 1985. – Vol. 3. – P. 1545–1552.
7. Farber S., Diamond L.K., Mercer R.D. et al. // N. Engl. J. Med. – 1948. – Vol. 238. – P. 787–793.
8. Frei E. III, Karon M., Levin R.H. et al. // Blood. – 1965. – Vol. 26. – P. 642–656.
9. Goker E., Waltham M., Kheradpour A. et al. // Blood. – 1995. – Vol. 86. – P. 677–684.
10. Gorlick R., Goker E., Trippett T. et al. // Blood. – 1997. – Vol. 89. – P. 1013–1018.
11. Guo W., Healey J.H., Meyers P.A. et al. // Clin. Cancer Res. – 1999. – Vol. 5. – P. 621–627.
12. Heinle R.W., Welch A.D. // J. Clin. Invest. – 1948. – Vol. 27. – P. 539.
13. Hertz R., Lewis J. Jr., Lipsett M.B. // Am. J. Obstet. Gynecol. – 1961. – Vol. 82. – P. 631–640.
14. Hooijberg J.H., Broxterman H.J., Kool M. et al. // Cancer Res. – 1999. – Vol. 59. – P. 2532–2535.
15. Kamen B.A., Smith A.K., Anderson R.G. // J. Clin. Invest. – 1991. – Vol. 87. – P. 1442–1449.
16. Kamen B.A., Wang M.T., Streckfuss A.J. et al. // J. Biol. Chem. – 1988. – Vol. 263. – P. 13602–13609.
17. Kane M.A., Elwood P.C., Portillo R.M. et al. // J. Clin. Invest. – 1988. – Vol. 81. – P. 1398–1406.
18. Kremer J.M. // Arthr. Rheum. – 2004. – Vol. 50. – P. 1370–1382.
19. Kufe D.W., Pollock R.E., Weichselbaum R.R. et al. Holland-Frei Cancer Medicine. – B.C. Decker, 2000.
20. Longo G.S., Gorlick R., Tong W.P. et al // Oncol. Res. – 1997. – Vol. 9. – P. 259–263.
21. Longo-Sorbello G.S., Bertino J.R. // Haematologica. – 2001. – Vol. 86. – P. 121–127.
22. McGuire J.J. // Curr. Pharm. Des. – 2003. – Vol. 9. – P. 2593–2613.
23. Nevozhay D., Budzynska R., Kanska U. et al. // Anticancer Res. – 2006 (в печати).
24. Nimec Z., Galivan J. // Arch. Biochem. Biophys. – 1983. – Vol. 226. – P. 671–680.
25. Robien K., Boynton A., Ulrich C.M. // Pharmacogenomics. – 2005. – Vol. 6. – P. 673–689.
26. Rodenhuis S., McGuire J.J., Narayanan R., Bertino J.R. // Cancer Res. – 1986. – Vol. 46. – P. 6513–6519.
27. Trippett T., Schlemmer S., Elisseyeff Y. et al // Blood. – 1992. – Vol. 80. – P. 1158–1162.
28. Weinblatt M.E., Maier A.L., Coblyn J.S. // J. Rheumatol. – 1993. – Vol. 20. – P. 950–952.
29. Westerhof G.R., Rijnboutt S., Schornagel J.H. et al // Cancer Res. – 1995. – Vol. 55. – P. 3795–3802.
30. Zhao R., Assaraf Y.G., Goldman I.D. // J. Biol. Chem. – 1998. – Vol. 273. – P. 19065–19071.
Review
For citations:
Nevozhaj D.V., Budzynskaya R., Kan’skaya U., Yagello M., Boratyn’sky Yu. MODERN IDEAS ABOUT THE MECHANISM OF ANTINEOPLASTIC ACTION OF METHOTREXATE AND RESISTANCE TO IT. Pacific Medical Journal. 2006;(4):12-16. (In Russ.)